LAMEA Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Theranostics Market would witness market growth of 18.3% CAGR during the forecast period (2023-2030).

The Brazil market dominated the LAMEA Theranostics Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $95.9 million by 2030. The Argentina market is showcasing a CAGR of 19% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 18% during (2023 - 2030).

Targeted therapies, including antiviral drugs, antibiotics, and immunomodulatory agents, deliver precise treatments tailored to the specific pathogens and host responses, improving clinical outcomes and reducing the spread of drug-resistant infections. Moreover, theranostics facilitate real-time monitoring and assessment of treatment response by providing quantitative and qualitative measures of disease progression and therapeutic efficacy.

Imaging techniques such as PET/CT, MRI, and ultrasound monitor changes in tumor size, metabolic activity, and perfusion dynamics, enabling early detection of treatment response or resistance. Molecular biomarkers, including circulating tumor DNA (ctDNA), tumor markers, and immune markers, assess treatment response at the molecular level, guiding adjustments to treatment regimens and therapeutic interventions.

The expansion of the healthcare sector in Saudi Arabia leads to improved access to healthcare services for the population, including advanced diagnostic and therapeutic technologies such as theranostics. According to the International Trade Administration data, Saudi Arabia contributes 60% of the healthcare expenditures of the Gulf Cooperation Council (GCC) nations, and the Saudi Arabian government continues to prioritize this sector. Thus, the expansion of the region's healthcare sector is propelling the market's growth.

Based on End User, the market is segmented into Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers. Based on Product, the market is segmented into Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services. Based on Application, the market is segmented into Prostate Cancer, Bone Metastasis, Other Cancers, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Bayer AG
GE HealthCare Technologies, Inc.
Siemens Healthineers AG (Siemens AG)
Cardinal Health, Inc.
Canon, Inc.
Clarity Pharmaceuticals Ltd
Koninklijke Philips N.V.
Thermo Fisher Scientific, Inc.
Telix Pharmaceuticals Limited
ABX advanced biochemical compounds GmbH

LAMEA Theranostics Market Report Segmentation

By End User

Hospitals & Cancer Care Centers
Theranostics Centers
Research & Academic Centers

By Product

Radiopharmaceuticals
Diagnostic Imaging
IVD/Biomarker Screening
Software & Services

By Application

Prostate Cancer
Bone Metastasis
Other Cancers
Others

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1LAMEA Theranostics Market, by End User
- 1.4.2LAMEA Theranostics Market, by Product
- 1.4.3LAMEA Theranostics Market, by Application
- 1.4.4LAMEA Theranostics Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter's Five Forces Analysis

Chapter 4.LAMEA Theranostics Market by End User

4.1LAMEA Hospitals & Cancer Care Centers Market by Country
4.2LAMEA Theranostics Centers Market by Country
4.3LAMEA Research & Academic Centers Market by Country

Chapter 5.LAMEA Theranostics Market by Product

5.1LAMEA Radiopharmaceuticals Market by Country
5.2LAMEA Diagnostic Imaging Market by Country
5.3LAMEA IVD/Biomarker Screening Market by Country
5.4LAMEA Software & Services Market by Country

Chapter 6.LAMEA Theranostics Market by Application

6.1LAMEA Prostate Cancer Market by Country
6.2LAMEA Bone Metastasis Market by Country
6.3LAMEA Other Cancers Market by Country
6.4LAMEA Others Market by Country

Chapter 7.LAMEA Theranostics Market by Country

7.1Brazil Theranostics Market
- 7.1.1Brazil Theranostics Market by End User
- 7.1.2Brazil Theranostics Market by Product
- 7.1.3Brazil Theranostics Market by Application
7.2Argentina Theranostics Market
- 7.2.1Argentina Theranostics Market by End User
- 7.2.2Argentina Theranostics Market by Product
- 7.2.3Argentina Theranostics Market by Application
7.3UAE Theranostics Market
- 7.3.1UAE Theranostics Market by End User
- 7.3.2UAE Theranostics Market by Product
- 7.3.3UAE Theranostics Market by Application
7.4Saudi Arabia Theranostics Market
- 7.4.1Saudi Arabia Theranostics Market by End User
- 7.4.2Saudi Arabia Theranostics Market by Product
- 7.4.3Saudi Arabia Theranostics Market by Application
7.5South Africa Theranostics Market
- 7.5.1South Africa Theranostics Market by End User
- 7.5.2South Africa Theranostics Market by Product
- 7.5.3South Africa Theranostics Market by Application
7.6Nigeria Theranostics Market
- 7.6.1Nigeria Theranostics Market by End User
- 7.6.2Nigeria Theranostics Market by Product
- 7.6.3Nigeria Theranostics Market by Application
7.7Rest of LAMEA Theranostics Market
- 7.7.1Rest of LAMEA Theranostics Market by End User
- 7.7.2Rest of LAMEA Theranostics Market by Product
- 7.7.3Rest of LAMEA Theranostics Market by Application

Chapter 8.Company Profiles

8.1Bayer AG
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5Recent strategies and developments:
  - 8.1.5.1Acquisition and Mergers:
- 8.1.6SWOT Analysis
8.2GE HealthCare Technologies, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Segmental and Regional Analysis
- 8.2.4Research & Development Expenses
- 8.2.5Recent strategies and developments:
  - 8.2.5.1Partnerships, Collaborations, and Agreements:
- 8.2.6SWOT Analysis
8.3Siemens Healthineers AG (Siemens AG)
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expense
- 8.3.5Recent strategies and developments:
  - 8.3.5.1Product Launches and Product Expansions:
- 8.3.6SWOT Analysis
8.4Cardinal Health, Inc.
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Segmental and Regional Analysis
- 8.4.4SWOT Analysis
8.5Canon, Inc.
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expenses
- 8.5.5SWOT Analysis
8.6Clarity Pharmaceuticals Ltd
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Research & Development Expenses
- 8.6.4SWOT Analysis
8.7Koninklijke Philips N.V.
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Segmental and Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Thermo Fisher Scientific, Inc.
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expenses
- 8.8.5SWOT Analysis
8.9Telix Pharmaceuticals Limited
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5SWOT Analysis
8.10.ABX advanced biochemical compounds GmbH
- 8.10.1Company Overview
- 8.10.2SWOT Analysis

LIST OF TABLES

TABLE 1LAMEA Theranostics Market, 2019 - 2022, USD Million
TABLE 2LAMEA Theranostics Market, 2023 - 2030, USD Million
TABLE 3LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 4LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 5LAMEA Hospitals & Cancer Care Centers Market by Country, 2019 - 2022, USD Million
TABLE 6LAMEA Hospitals & Cancer Care Centers Market by Country, 2023 - 2030, USD Million
TABLE 7LAMEA Theranostics Centers Market by Country, 2019 - 2022, USD Million
TABLE 8LAMEA Theranostics Centers Market by Country, 2023 - 2030, USD Million
TABLE 9LAMEA Research & Academic Centers Market by Country, 2019 - 2022, USD Million
TABLE 10LAMEA Research & Academic Centers Market by Country, 2023 - 2030, USD Million
TABLE 11LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 12LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 13LAMEA Radiopharmaceuticals Market by Country, 2019 - 2022, USD Million
TABLE 14LAMEA Radiopharmaceuticals Market by Country, 2023 - 2030, USD Million
TABLE 15LAMEA Diagnostic Imaging Market by Country, 2019 - 2022, USD Million
TABLE 16LAMEA Diagnostic Imaging Market by Country, 2023 - 2030, USD Million
TABLE 17LAMEA IVD/Biomarker Screening Market by Country, 2019 - 2022, USD Million
TABLE 18LAMEA IVD/Biomarker Screening Market by Country, 2023 - 2030, USD Million
TABLE 19LAMEA Software & Services Market by Country, 2019 - 2022, USD Million
TABLE 20LAMEA Software & Services Market by Country, 2023 - 2030, USD Million
TABLE 21LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 22LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 23LAMEA Prostate Cancer Market by Country, 2019 - 2022, USD Million
TABLE 24LAMEA Prostate Cancer Market by Country, 2023 - 2030, USD Million
TABLE 25LAMEA Bone Metastasis Market by Country, 2019 - 2022, USD Million
TABLE 26LAMEA Bone Metastasis Market by Country, 2023 - 2030, USD Million
TABLE 27LAMEA Other Cancers Market by Country, 2019 - 2022, USD Million
TABLE 28LAMEA Other Cancers Market by Country, 2023 - 2030, USD Million
TABLE 29LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 30LAMEA Others Market by Country, 2023 - 2030, USD Million
TABLE 31LAMEA Theranostics Market by Country, 2019 - 2022, USD Million
TABLE 32LAMEA Theranostics Market by Country, 2023 - 2030, USD Million
TABLE 33Brazil Theranostics Market, 2019 - 2022, USD Million
TABLE 34Brazil Theranostics Market, 2023 - 2030, USD Million
TABLE 35Brazil Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 36Brazil Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 37Brazil Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 38Brazil Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 39Brazil Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 40Brazil Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 41Argentina Theranostics Market, 2019 - 2022, USD Million
TABLE 42Argentina Theranostics Market, 2023 - 2030, USD Million
TABLE 43Argentina Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 44Argentina Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 45Argentina Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 46Argentina Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 47Argentina Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 48Argentina Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 49UAE Theranostics Market, 2019 - 2022, USD Million
TABLE 50UAE Theranostics Market, 2023 - 2030, USD Million
TABLE 51UAE Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 52UAE Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 53UAE Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 54UAE Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 55UAE Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 56UAE Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 57Saudi Arabia Theranostics Market, 2019 - 2022, USD Million
TABLE 58Saudi Arabia Theranostics Market, 2023 - 2030, USD Million
TABLE 59Saudi Arabia Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 60Saudi Arabia Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 61Saudi Arabia Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 62Saudi Arabia Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 63Saudi Arabia Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 64Saudi Arabia Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 65South Africa Theranostics Market, 2019 - 2022, USD Million
TABLE 66South Africa Theranostics Market, 2023 - 2030, USD Million
TABLE 67South Africa Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 68South Africa Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 69South Africa Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 70South Africa Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 71South Africa Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 72South Africa Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 73Nigeria Theranostics Market, 2019 - 2022, USD Million
TABLE 74Nigeria Theranostics Market, 2023 - 2030, USD Million
TABLE 75Nigeria Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 76Nigeria Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 77Nigeria Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 78Nigeria Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 79Nigeria Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 80Nigeria Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 81Rest of LAMEA Theranostics Market, 2019 - 2022, USD Million
TABLE 82Rest of LAMEA Theranostics Market, 2023 - 2030, USD Million
TABLE 83Rest of LAMEA Theranostics Market by End User, 2019 - 2022, USD Million
TABLE 84Rest of LAMEA Theranostics Market by End User, 2023 - 2030, USD Million
TABLE 85Rest of LAMEA Theranostics Market by Product, 2019 - 2022, USD Million
TABLE 86Rest of LAMEA Theranostics Market by Product, 2023 - 2030, USD Million
TABLE 87Rest of LAMEA Theranostics Market by Application, 2019 - 2022, USD Million
TABLE 88Rest of LAMEA Theranostics Market by Application, 2023 - 2030, USD Million
TABLE 89Key Information - Bayer AG
TABLE 90Key Information - GE HealthCare Technologies, Inc.
TABLE 91Key Information - Siemens Healthineers AG
TABLE 92key information - Cardinal Health, Inc.
TABLE 93Key Information - Canon, Inc.
TABLE 94Key Information - Clarity Pharmaceuticals Ltd
TABLE 95Key Information - Koninklijke Philips N.V.
TABLE 96Key Information - Thermo Fisher Scientific, Inc.
TABLE 97Key Information - Telix Pharmaceuticals Limited
TABLE 98Key Information - ABX advanced biochemical compounds GmbH

LAMEA Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents